A Randomized, Open-label Study to Characterize the Pharmacokinetics of Inhaled Oxytocin (GR121619) Compared With IM Oxytocin in Women in the Third Stage of Labour, and With IV Oxytocin in Non-pregnant, Non-lactating Women of Childbearing Potential
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Oxytocin (Primary) ; Oxytocin (Primary) ; Oxytocin (Primary)
- Indications Postpartum haemorrhage
- Focus Adverse reactions; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 01 Mar 2018 Planned End Date changed from 28 Aug 2018 to 24 Dec 2018.
- 01 Mar 2018 Planned primary completion date changed from 28 Aug 2018 to 24 Dec 2018.
- 12 Jan 2018 Planned End Date changed from 15 Feb 2018 to 28 Aug 2018.